ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Yoshifumi Naka
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naka, Y.
Right arrow Articles by Belov, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naka, Y.
Right arrow Articles by Belov, D.
Related Collections
Right arrow Coronary disease

Ann Thorac Surg 2006;81:642
© 2006 The Society of Thoracic Surgeons

Original article: Cardiovascular

Invited commentary

Yoshifumi Naka, MD, PhD, Dmitri Belov, MD

Division of Surgery, Columbia University, Milstein Building, 177 Fort Washington Ave, New York, NY 310032

(Email: yn33@columbia.edu; db711@columbia.edu).

The first 20% of the full text of this article appears below.

This article by Boodhwani and colleagues [1] evaluates the possible mechanisms responsible for impairment of ischemia-induced angiogenesis by hypercholesterolemia. The single most important observation made in this report is that hypercholesterolemia directly impairs the balance of stimulatory and inhibitory factors of angiogenesis. The production of endostatin was significantly upregulated in the group with a high cholesterol level. . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.